Old Web
English
Sign In
Acemap
>
authorDetail
>
Sarah-Jane Anderson
Sarah-Jane Anderson
GlaxoSmithKline
Medicine
cost effectiveness
Internal medicine
human immunodeficiency virus
Abacavir
4
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Cost-Effectiveness of Juluca (dolutegravir/rilpivirine) for Human Immunodeficiency Virus (HIV-1) Infection Treatment in Virologically Suppressed Adults in Taiwan.
2021
Value in health regional issues
Sarah-Jane Anderson
Chiung-Yuan Hsu
Huang-Tz Ou
Nai-Ying Ko
Chun Ting Yang
Sara Lopes
Show All
Source
Cite
Save
Citations (0)
Cost-effectiveness and budget impact of dolutegravir/lamivudine for treatment of human immunodeficiency virus (HIV-1) infection in the United States
2021
Journal of managed care & specialty pharmacy
Karin Butler
Sarah-Jane Anderson
Olivia Hayward
I. Jacob
Yogesh Punekar
Lee Alexandra Evitt
Alan Oglesby
Show All
Source
Cite
Save
Citations (0)
Patient-Reported Outcomes in the Phase III BRIGHTE Trial of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Heavily Treatment-Experienced Individuals
2021
The Patient: Patient-Centered Outcomes Research
Sarah-Jane Anderson
Miranda Murray
David Cella
Robert M. Grossberg
Debbie Hagins
William Towner
Marcia Wang
Andrew P. Clark
Amy Pierce
Cyril Llamoso
Peter Ackerman
Max Lataillade
Show All
Source
Cite
Save
Citations (0)
1018. Health Technology Assessment of New Long-Acting, Directly-Observed HIV Treatments in Canada: Impact of Real-World Adherence to Daily Oral Therapy on Treatment, Transmission and Cost-Effectiveness
2020
Open Forum Infectious Diseases
Erin Arthurs
Ben Parker
I. Jacob
Debbie Becker
Amy Lee
Olivia Hayward
Vasiliki Chounta
Sarah-Jane Anderson
Nicolas Van de Velde
Show All
Source
Cite
Save
Citations (0)
1